New Delhi (Sputnik): Back in April, India’s federal drug regulator cleared a proposal by the country’s top biomedical research body for the clinical trial of convalescent plasma for COVID-19 patients. The trials are now being conducted by hospitals/research laboratories approved by the Indian Council of Medical Research (ICMR).
